Pharvaris PHVS
NASDAQ PHVS
$36.13 +0.47 (+1.30%)
As of: Sep 4, 2026 · 12:51 PM EDT

Pharvaris (PHVS) Shares Outstanding (2019 - 2026)

Pharvaris' (PHVS) quarterly Shares Outstanding (Entity) came in at $65.3 million in Q1 2026, up 19.85% YoY from $54.5 million in Q1 2025, and little changed on a QoQ basis from $65.2 million in Q4 2025.

Analysis

Pharvaris (PHVS) Shares Outstanding (2019 - 2026) Analysis & Trends

Pharvaris (PHVS) has 8 years of Shares Outstanding (Entity) data on file, last reported at $65.3 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 19.85% year-over-year to $65.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $65.3 million (up 19.85% YoY) and the FY2025 annual result came in at $65.2 million, up 19.92% from the prior year.
  • Shares Outstanding (Entity) steadied at $65.3 million in Q1 2026, from $65.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $65.3 million in Q1 2026 to a low of $33.1 million in Q1 2022.
  • A 5-year average of $47.5 million and a median of $53.7 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) jumped 263.94% — and 2025, when it climbed 1.35%.
  • Tracing PHVS's Shares Outstanding (Entity) over 5 years: stood at $33.8 million in 2022, then advanced by 13.53% to $38.4 million in 2023, then surged by 41.64% to $54.4 million in 2024, then grew by 19.92% to $65.2 million in 2025, then grew by 0.15% to $65.3 million in 2026.
  • The last three Shares Outstanding (Entity) figures came in at $65.3 million (Q1 2026), $65.2 million (Q4 2025), and $62.3 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn 61.30 Mn
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - 210.89 Mn
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 111.58 Mn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn 133.61 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn - 445.06 Mn
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn 217.35 Mn
10 Pharvaris 2.14 Bn 1.77 Bn 85,072.10 59.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 59.16 Mn
Mar 31, 2026 59.16 Mn
Dec 31, 2025 59.16 Mn
Sep 30, 2025 54.02 Mn
Jun 30, 2025 54.02 Mn
Mar 31, 2025 54.02 Mn
Dec 31, 2024 54.02 Mn
Sep 30, 2024 38.39 Mn
Jun 30, 2024 38.39 Mn
Mar 31, 2024 38.39 Mn
Dec 31, 2023 38.39 Mn
Sep 30, 2023 33.59 Mn
Jun 30, 2023 33.59 Mn
Mar 31, 2023 33.59 Mn
Dec 31, 2022 33.59 Mn
Sep 30, 2022 30.41 Mn
Jun 30, 2022 30.41 Mn
Mar 31, 2022 30.41 Mn
Dec 31, 2021 30.41 Mn
Sep 30, 2021 18.72 Mn